These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 21478212

  • 21. Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population.
    Bucková D, Izakovicová Hollá L, Vácha J.
    Allergy; 2002 May; 57(5):446-8. PubMed ID: 11972486
    [Abstract] [Full Text] [Related]

  • 22. Associations of the IL12B promoter polymorphism in longitudinal data from asthmatic patients 7 to 42 years of age.
    Khoo SK, Hayden CM, Roberts M, Horak E, de Klerk N, Zhang G, Robertson CF, Goldblatt J, Le Souëf P.
    J Allergy Clin Immunol; 2004 Mar; 113(3):475-81. PubMed ID: 15007350
    [Abstract] [Full Text] [Related]

  • 23. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
    Ramón LA, Gilabert-Estellés J, Cosín R, Gilabert J, España F, Castelló R, Chirivella M, Romeu A, Estellés A.
    Thromb Res; 2008 Mar; 122(6):854-60. PubMed ID: 18423526
    [Abstract] [Full Text] [Related]

  • 24. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
    Pérez-Martínez P, Adarraga-Cansino MD, Fernández de la Puebla RA, Blanco-Molina A, Delgado-Lista J, Marín C, Ordovás JM, López-Miranda J, Pérez-Jiménez F.
    Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
    Jiang YW, Sun YC, Zhou QT, Gai XY, Cao WL, Yao WZ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Plasminogen activator inhibitor-1 (PAI-1) 4 G/5 G polymorphism and endometrial cancer. Influence of PAI-1 polymorphism on tissue PAI-1 antigen and mRNA expression and tumor severity.
    Gilabert-Estellés J, Ramón LA, Braza-Boïls A, Gilabert J, Chirivella M, España F, Estellés A.
    Thromb Res; 2012 Aug; 130(2):242-7. PubMed ID: 22055623
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
    Matsubara Y, Murata M, Isshiki I, Watanabe R, Zama T, Watanabe G, Watanabe K, Ikeda Y.
    Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Association of 4G/5G polymorphism in PAI1 promoter with PAI1 level in deep vein thrombosis.
    Chen YL, Zhang JX, Wang PX, Cui RZ, Zhao FM, Mao YM, Li JY, Bi YY, Li H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):624-7. PubMed ID: 16331557
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.
    Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080
    [Abstract] [Full Text] [Related]

  • 36. Plasminogen activator inhibitor-1 4G/5G genetic polymorphism does not affect peritoneal transport characteristic.
    Szeto CC, Poon P, Szeto CY, Wong TY, Lai KB, Li PK.
    Am J Kidney Dis; 2002 May 01; 39(5):1061-7. PubMed ID: 11979351
    [Abstract] [Full Text] [Related]

  • 37. Inhaled corticosteroids in children: use and effects of early treatment on asthma and lung function. Prevalence of asthma and the impact of severity in early life on later asthma in childhood.
    Devulapalli CS.
    Clin Respir J; 2008 Oct 01; 2(4):247-8. PubMed ID: 20298343
    [Abstract] [Full Text] [Related]

  • 38. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G.
    J Clin Periodontol; 2007 Apr 01; 34(4):278-84. PubMed ID: 17257155
    [Abstract] [Full Text] [Related]

  • 39. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex.
    Dijkstra A, Vonk JM, Jongepier H, Koppelman GH, Schouten JP, ten Hacken NH, Timens W, Postma DS.
    Thorax; 2006 Feb 01; 61(2):105-10. PubMed ID: 16308336
    [Abstract] [Full Text] [Related]

  • 40. Plasminogen activator inhibitor I 4G/5G polymorphism in neonatal respiratory distress syndrome.
    Armangil D, Yurdakök M, Okur H, Gürgey A.
    Clin Appl Thromb Hemost; 2011 Aug 01; 17(4):352-7. PubMed ID: 20460339
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.